TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

[1]  T. Doetschman,et al.  Endogenous Transforming Growth Factor β1 Suppresses Inflammation and Promotes Survival in Adult CNS , 2007, The Journal of Neuroscience.

[2]  D. Butterfield,et al.  Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment , 2007 .

[3]  E. Rizzarelli,et al.  Aβ(25–35) and its C‐ and/or N‐blocked derivatives: Copper driven structural features and neurotoxicity , 2007, Journal of neuroscience research.

[4]  S. Love,et al.  Neurofibrillary Tangles May Interfere With Smad 2/3 Signaling in Neurons , 2007, Journal of neuropathology and experimental neurology.

[5]  G. Perry,et al.  Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? , 2006, Journal of neuroscience research.

[6]  L. Mucke,et al.  Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.

[7]  E. Aronica,et al.  DNA Polymerase-β Is Expressed Early in Neurons of Alzheimer's Disease Brain and Is Loaded into DNA Replication Forks in Neurons Challenged with β-Amyloid , 2006, The Journal of Neuroscience.

[8]  T. Arendt,et al.  Altered subcellular location of phosphorylated Smads in Alzheimer's disease , 2006, The European journal of neuroscience.

[9]  E. Castrén,et al.  Neurotrophins and Dementia—Keeping in Touch , 2006, Neuron.

[10]  T. Wyss-Coray.  Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. , 2006, Current Alzheimer research.

[11]  Zaira García,et al.  Phosphoinositide 3‐kinase controls early and late events in mammalian cell division , 2006, The EMBO journal.

[12]  T. Wyss-Coray,et al.  Reduced brain tissue perfusion in TGF-β1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities , 2005, Neurobiology of Disease.

[13]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[14]  T. Wyss-Coray,et al.  Small molecule tgf-beta mimetics as potential neuroprotective factors. , 2005, Current Alzheimer research.

[15]  C. Swanson,et al.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders , 2005, Nature Reviews Drug Discovery.

[16]  C. Culmsee,et al.  Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways , 2004, Neuroscience.

[17]  Miguel Bronfman,et al.  Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease , 2004, Brain Research Reviews.

[18]  M. Caruso,et al.  Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. , 2004, Endocrinology.

[19]  K. Herrup,et al.  Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death , 2004, The Journal of Neuroscience.

[20]  P. Dodd,et al.  Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease , 2004, Neurochemistry International.

[21]  E. Aronica,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.

[22]  G. Shapiro.  Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol , 2004, Clinical Cancer Research.

[23]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[24]  R. Brinton.  Impact of Estrogen Therapy on Alzheimer’s Disease , 2004, CNS drugs.

[25]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[26]  R. Malenka,et al.  β-catenin is critical for dendritic morphogenesis , 2003, Nature Neuroscience.

[27]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[28]  A. Caricasole,et al.  Erratic expression of DNA polymerases by β‐amyloid causes neuronal death , 2002 .

[29]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[30]  E. Schuman,et al.  Depolarization Drives β-Catenin into Neuronal Spines Promoting Changes in Synaptic Structure and Function , 2002, Neuron.

[31]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[32]  P. Grammas,et al.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. , 2002, The American journal of pathology.

[33]  A. Zeiher,et al.  Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation* , 2002, The Journal of Biological Chemistry.

[34]  B. Hemmings,et al.  Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.

[35]  B. Lamb,et al.  Transgenic mouse models of Alzheimer's disease. , 2001, Trends in genetics : TIG.

[36]  N. Kowall,et al.  Hippocampal Injections of Amyloid β-Peptide 1-40 Impair Subsequent One-Trial/Day Reward Learning , 2001, Neurobiology of Learning and Memory.

[37]  D. Rubinow,et al.  Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. , 2001, Neuroreport.

[38]  H. Shibasaki,et al.  α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity* , 2001, The Journal of Biological Chemistry.

[39]  V. Haroutunian,et al.  Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. , 2000, Archives of neurology.

[40]  F. Nicoletti,et al.  Mitotic signaling by β‐amyloid causes neuronal death , 1999 .

[41]  David S. Park,et al.  Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.

[42]  K. Flanders,et al.  Effects of Transforming Growth Factor-β (Isoforms 1–3) on Amyloid-β Deposition, Inflammation, and Cell Targeting in Organotypic Hippocampal Slice Cultures , 1998, The Journal of Neuroscience.

[43]  F. Nicoletti,et al.  Neuroprotection by Glial Metabotropic Glutamate Receptors Is Mediated by Transforming Growth Factor-β , 1998, The Journal of Neuroscience.

[44]  Edward S. Kim,et al.  Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25–35 in cultured neuronal cells , 1998 .

[45]  M. Mercken,et al.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Takashima,et al.  Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons , 1998, Neuroscience Research.

[47]  M. Dragunow,et al.  The role of neuronal growth factors in neurodegenerative disorders of the human brain , 1998, Brain Research Reviews.

[48]  J. Miguel-Hidalgo,et al.  β-Amyloid(1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield , 1998, Acta Neuropathologica.

[49]  K. Yoshimi,et al.  Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons , 1998, Neuroscience.

[50]  Philip R. Cohen,et al.  Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216 , 1997, FEBS letters.

[51]  L. Mucke,et al.  Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.

[52]  K. Flanders,et al.  Transforming growth factor-β protects human hNT cells from degeneration induced by β-amyloid peptide: involvement of the TGF-β type II receptor , 1997 .

[53]  K. Flanders,et al.  Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide , 1996, Brain Research.

[54]  John Calvin Reed,et al.  Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. , 1996, Molecular pharmacology.

[55]  F. Nicoletti,et al.  Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. , 1995, Molecular pharmacology.

[56]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  W. Lamm,et al.  Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.